Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

Clinical trial NCT04602390 · COMPLETED

Trial details

NCT number: NCT04602390
Sponsor: Anokion SA
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)Relapsing Remitting Multiple Sclerosis

Start date: 2020-11-06
Primary completion: 2024-04-23
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.